pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4529 |
Genomic Coordinates | chr18: 55479221 - 55479298 |
Description | Homo sapiens miR-4529 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4529-5p | ||||||||||||
Sequence | 6| AGGCCAUCAGCAGUCCAAUGAA |27 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | Illumina | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BCL9L | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | BCL9-2, DLNB11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | B-cell CLL/lymphoma 9 like | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_182557 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on BCL9L | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of BCL9L (miRNA target sites are highlighted) |
>BCL9L|NM_182557|3'UTR 1 AAGTCGCTGCCAGGGCTGGAGCCGGGGCAATGTTGCAAATACGATAACCTTAACAAAGTTCTTCCCCTCAATGTTGGGAT 81 GGCCTGGGTCGCGGGGTGGGGTGGAGGGGGTGGGAGGGGGCTTGTGTAGGGAGTGGCATTTGTGGAAACCAGATGTGCTG 161 GCAGCTTAGGGGGAAGTGGCAGTGTGGGGTGGGGGATTTTGCATTGGGGTTGGTTCCATTTCGGCCACCAGGACTGCCCC 241 TCCCCCACTCCTCCCAATTCCTATGGAGCCTCTCTATTTTACCTCTTTCCGTGCATCCCTGCACCCGCCACACCCCCTTC 321 AGCTATGCTTTTGGAGTCCTGGATGGGAATCTGGGGGGAGAGAGGAAGGACAGGTCAGGTCTCCCCCAGCCCCTTCTGCT 401 CCTGTCTCCTCGTGTCCGCATTGCTGGAGCTCCACCTCCCTCTTGGTTTCTCCGCACCCGCCCATTTTCCTTCTGTCTTT 481 ACCTGCTTCGTATCCTTTCCCTGCTGATGTGGCTGACCCCTCTCCCACCCCTCCCTGCAGGCGGCTGGCCAGGTGGGCAG 561 GTGCCAGCCGGAGCTGTAAATAGAGCGCTGCGCTTTTGTGCTGGTTTGTGCGTGTGCTGTATTTCTGTGTTTTGATAGAA 641 GTCACACAAAAAAAAAAGGATAAAAGAAACCCTTCCCCCCTTCTTCAAGTTATTGCTCCCTCCATTCCCCTGGACCCAGG 721 GACATGCAGCCCTACATGGCCACCCACTGTTTGCAGTGTCTCTGGGTCCCTAAGGGATACCATTCCTGTCTCGTCCCCAA 801 ATGGTAAGATGACGTAAATGACCCACTCCTAAACTGAGGTCAGACCACCTAGGCTTCCACCTGGTGAGCCCTAGCAGGGC 881 TGAGACCCCCAGGGCGGCAGCCTGTCTGCTGCTGAGTGATTCAGGGAGAACATGTGTGCACGTGCATGTGTGTTTGCCCA 961 CACCGGTGACACGGGGCCCTGGCTTTCCACTTTGGATGCCCGGGCATCCGCTGCTGCTACATCTTAGCCAGAACTTGAAG 1041 TCTTTTGTCCCAGTTTGGGATGAAGGAAAGGAGGAAGAGGCGGTGGCTGTGTGGCCCCCTTGAGTGGAGCCATGGAAGGG 1121 GTGGCATGGTGCCACTGGGGCCTGTGGCTGTAGTAGCCCTGGGCCAGGTAACCTCCAGGGCCCTGACTTTTCCAGAGGCT 1201 GCTGCCACCTACTTCTTATCAAAGAAGGGGGAGAACAGTTCATCTGAGTCAGTGCACCTCCCCTCCAGTCTCCACTCCCT 1281 GAGGATGGAATCGGGGAAACAGCATCCTGCCGCCTCCTCTCTGCCTGCCCACTCACCGGCAAGGTTGTCCCTCTGCCCAG 1361 GGCTCAGGGCCATGTACCAGATCTGTCTGTGCCCACCCAGGCACAGCCACTGCCTCCCCCTTGGCTCCCTGCTCCTACCC 1441 AGGAGAGCTCCCTATCCGCCTTTGGTCAGAGCTGAAGCCATATACGACTGGGTGTTTGTCCCCCTACTTTGGCCCCAGGA 1521 GTAAAAAAACTTCTCCTTTTCTCACTTCCTTTCCTGCCTCGGGAGGTGGCAGGGCAGTTCCCTGGCTGAGGCCTTTTGCG 1601 CCCCACCTCCAGGACCAAGGGCCATTCTAGACAGGGTGTCTTCTACCAGGACCCGTCCCTAGCCTTCCTGGCCTGGAGGG 1681 CCTGGTCTTGCACTGGCAGCTGTAATACAAAGGGAACTCGCCCCACTTCTCCCAGCCTGGTGCTGTCCTCTCGGCCCACC 1761 ATCGGCCAGGTCCAGCGCTTCCTCTGGGGCTGACAACAGGCCCCTGACTCACCCCGGTCACCTCCCAGGGTCCATGGCCA 1841 GGGCCTCTGTGTTTGGGGGGCCACTTGCCCTTCATCCTGCCAGGCGCTTTGCCCGCCCTGCCTCAGCCTGGGCCCTGTGC 1921 CCTTGAGCCCTCCACCCCTGGCCCAAGACCCCCCCAAACTGTCTGACTCTGTGTTTCCTGCCCTGAGGAGAGAGGGGTCA 2001 GATTGCAGCGGGCCGAGTGCCCTCTCCGTCCCCTCTCCTCCCACCCACGCCACAGGCCAGCCTACTCTTCCCTCCATCCA 2081 TGGCCACACCCCCAGCCATTTTGTACCATTATATAAATATATATATAAATATAAATATATAAATACAATATGTGAAGACA 2161 TCTTCTTGGTTTTTATTTTGAAACAATTTTTAGGCTTGTTCCGGGGGTCTCTGTGCTGCCTGTACTGTATTGACCTGTTT 2241 TATAGGTGCCTTTTTATTAAAAAGAAAATTCAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000334801.3 | 3UTR | CCUACUCUUCCCUCCAUCCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
57 hsa-miR-4529-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT226211 | TMEM64 | transmembrane protein 64 | 2 | 2 | ||||||||
MIRT241576 | LAMC1 | laminin subunit gamma 1 | 2 | 8 | ||||||||
MIRT311423 | LMNB1 | lamin B1 | 2 | 2 | ||||||||
MIRT458476 | RMI1 | RecQ mediated genome instability 1 | 2 | 10 | ||||||||
MIRT476949 | FAM83G | family with sequence similarity 83 member G | 2 | 2 | ||||||||
MIRT480886 | BCL9L | B-cell CLL/lymphoma 9 like | 2 | 2 | ||||||||
MIRT492825 | NXN | nucleoredoxin | 2 | 4 | ||||||||
MIRT495860 | CLCN6 | chloride voltage-gated channel 6 | 2 | 2 | ||||||||
MIRT495919 | FBXO41 | F-box protein 41 | 2 | 2 | ||||||||
MIRT497150 | PRDM15 | PR/SET domain 15 | 2 | 2 | ||||||||
MIRT498695 | LYRM2 | LYR motif containing 2 | 2 | 4 | ||||||||
MIRT499954 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT501309 | RPS21 | ribosomal protein S21 | 2 | 2 | ||||||||
MIRT505941 | RAP2C | RAP2C, member of RAS oncogene family | 2 | 4 | ||||||||
MIRT508422 | SFTPB | surfactant protein B | 2 | 2 | ||||||||
MIRT510705 | SREK1IP1 | SREK1 interacting protein 1 | 2 | 6 | ||||||||
MIRT513225 | RYK | receptor-like tyrosine kinase | 2 | 2 | ||||||||
MIRT513775 | PER1 | period circadian clock 1 | 2 | 6 | ||||||||
MIRT514948 | CD36 | CD36 molecule | 2 | 2 | ||||||||
MIRT515902 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT516066 | RAB42 | RAB42, member RAS oncogene family | 2 | 2 | ||||||||
MIRT523010 | IL6R | interleukin 6 receptor | 2 | 2 | ||||||||
MIRT525065 | FRK | fyn related Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT530304 | TNFRSF10D | TNF receptor superfamily member 10d | 2 | 2 | ||||||||
MIRT530445 | SULT1B1 | sulfotransferase family 1B member 1 | 2 | 2 | ||||||||
MIRT532421 | ITFG2 | integrin alpha FG-GAP repeat containing 2 | 2 | 2 | ||||||||
MIRT532626 | PHF5A | PHD finger protein 5A | 2 | 2 | ||||||||
MIRT535128 | PLK2 | polo like kinase 2 | 2 | 2 | ||||||||
MIRT539608 | SHISA9 | shisa family member 9 | 2 | 2 | ||||||||
MIRT539640 | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | 2 | 2 | ||||||||
MIRT540213 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT540333 | OPHN1 | oligophrenin 1 | 2 | 2 | ||||||||
MIRT544350 | EGLN1 | egl-9 family hypoxia inducible factor 1 | 2 | 2 | ||||||||
MIRT547521 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT548546 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT554545 | RRN3 | RRN3 homolog, RNA polymerase I transcription factor | 2 | 2 | ||||||||
MIRT558545 | CSNK1A1 | casein kinase 1 alpha 1 | 2 | 2 | ||||||||
MIRT558619 | CNOT6L | CCR4-NOT transcription complex subunit 6 like | 2 | 4 | ||||||||
MIRT563009 | U2AF2 | U2 small nuclear RNA auxiliary factor 2 | 2 | 2 | ||||||||
MIRT565148 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT567297 | HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 2 | 2 | ||||||||
MIRT569071 | CADM2 | cell adhesion molecule 2 | 2 | 2 | ||||||||
MIRT570338 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 2 | ||||||||
MIRT573548 | RHOA | ras homolog family member A | 2 | 2 | ||||||||
MIRT573955 | FIGNL1 | fidgetin like 1 | 2 | 2 | ||||||||
MIRT608235 | PARP15 | poly(ADP-ribose) polymerase family member 15 | 2 | 2 | ||||||||
MIRT610627 | SPTA1 | spectrin alpha, erythrocytic 1 | 2 | 6 | ||||||||
MIRT613784 | RPS6 | ribosomal protein S6 | 2 | 2 | ||||||||
MIRT620437 | CARNS1 | carnosine synthase 1 | 2 | 2 | ||||||||
MIRT629393 | CLEC17A | C-type lectin domain containing 17A | 2 | 2 | ||||||||
MIRT637409 | NKX2-3 | NK2 homeobox 3 | 2 | 2 | ||||||||
MIRT659086 | DENR | density regulated re-initiation and release factor | 2 | 2 | ||||||||
MIRT687349 | NUP98 | nucleoporin 98 | 2 | 2 | ||||||||
MIRT688532 | DCAF7 | DDB1 and CUL4 associated factor 7 | 2 | 2 | ||||||||
MIRT701007 | PCSK6 | proprotein convertase subtilisin/kexin type 6 | 2 | 2 | ||||||||
MIRT715878 | ACIN1 | apoptotic chromatin condensation inducer 1 | 2 | 2 | ||||||||
MIRT723149 | NQO2 | N-ribosyldihydronicotinamide:quinone reductase 2 | 2 | 2 |